Ambiq Micro, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 10, 2026, reporting a net loss of $7.056 million on net sales of $38.138 million for the third quarter.

Key Highlights

  • Net sales more than doubled: Third-quarter net sales reached $38.138 million, up from $18.165 million in the same quarter of 2025, according to the filing.
  • Net loss narrowed year over year: The company reported a net loss of $7.056 million for Q3 2026, compared to a net loss of $9.002 million in Q3 2025.
  • Nine-month net sales rose sharply: For the nine months ended September 30, 2026, net sales totaled $97.099 million versus $51.770 million for the same period in 2025.
  • Cash position expanded significantly: Cash and cash equivalents stood at $363.452 million as of September 30, 2026, up from $140.275 million at December 31, 2025.
  • Follow-on offering raised capital: The filing discloses issuance of 4,936,651 shares of common stock in connection with follow-on offerings, net of deferred offering costs, generating $243.282 million in additional paid-in capital during the nine-month period.
  • Shares outstanding increased: As of November 6, 2026, 24,880,872 shares of common stock were outstanding, compared to 18,316,928 shares at December 31, 2025.
  • Total assets grew to $434.895 million: Total assets at September 30, 2026 were $434.895 million, up from $184.680 million at December 31, 2025.

Ambiq Micro's Third-Quarter 2026 Financial Results and Balance Sheet Position

According to the filing, Ambiq Micro, Inc. (NYSE:AMBQ) reported net sales of $38.138 million for the three months ended September 30, 2026, more than double the $18.165 million recorded in the year-ago quarter. Cost of sales for the quarter was $20.315 million, yielding gross profit of $17.823 million, compared to gross profit of $7.677 million in Q3 2025. Total operating expenses for the quarter were $27.851 million, including research and development costs of $16.297 million and selling, general and administrative expenses of $11.554 million.

The company disclosed a loss from operations of $10.028 million for Q3 2026, essentially flat with the $10.043 million operating loss reported in Q3 2025. Other income, net, of $2.976 million partially offset the operating loss, resulting in a net loss before income taxes of $7.052 million. After a provision for income taxes of $4 thousand, the net loss for the quarter was $7.056 million, or $(0.29) per basic and diluted share, based on weighted-average shares of 24,274,796. For the nine months ended September 30, 2026, the company reported a net loss of $24.342 million on net sales of $97.099 million.

The balance sheet as of September 30, 2026 reflects total assets of $434.895 million and total liabilities of $29.518 million, leaving total stockholders' equity of $405.377 million. The accumulated deficit stood at $381.053 million. Additional paid-in capital reached $786.731 million, reflecting the follow-on share issuances and stock-based compensation of $10.936 million recorded over the nine-month period. The company also noted 500,000,000 shares authorized under its certificate of incorporation, with 24,516,643 shares issued and outstanding at September 30, 2026.

What Was Disclosed

Ambiq Micro disclosed its unaudited condensed consolidated financial results for Q3 and the first nine months of 2026, covering revenue growth, operating losses, a substantially larger cash position following follow-on equity offerings, and an increase in shares outstanding.